Fortress Biotech Pref Preferred Stock Today
| FBIOP Preferred Stock | USD 5.41 0.20 3.57% |
Performance0 of 100
| Odds Of DistressOver 61
|
Fortress Biotech is selling at 5.41 as of the 21st of September 2024; that is 3.57% down since the beginning of the trading day. The preferred stock's last reported lowest price was 5.28. Fortress Biotech has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Fortress Biotech Pref are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 21st of September 2024. Click here to learn more.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 56.68 M outstanding shares of which 245 shares are currently shorted by private and institutional investors with about 0.02 days to cover all short positions. More on Fortress Biotech Pref
Moving together with Fortress Preferred Stock
Moving against Fortress Preferred Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Fortress Preferred Stock Highlights
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Fortress Biotech's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Fortress Biotech's managers, analysts, and investors.
Environmental | Governance | Social |
| Chairman | Lindsay Rosenwald |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Fortress Biotech Pref (FBIOP) is traded on NASDAQ Exchange in USA. It is located in 1111 Kane Concourse, Bay Harbor Islands, FL, United States, 33154 and employs 173 people. Fortress Biotech is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 107.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fortress Biotech's market, we take the total number of its shares issued and multiply it by Fortress Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fortress Biotech Pref classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 56.68 M outstanding shares of which 245 shares are currently shorted by private and institutional investors with about 0.02 days to cover all short positions.
Fortress Biotech Pref has accumulated about 248.77 M in cash with (116.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31.
Check Fortress Biotech Probability Of Bankruptcy
Ownership AllocationFortress Biotech holds a total of 56.68 Million outstanding shares. Roughly 98.2 percent of Fortress Biotech outstanding shares are held by general public with 1.8 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Fortress Ownership Details
Fortress Biotech Pref Risk Profiles
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.29) | |||
| Total Risk Alpha | (2.27) | |||
| Treynor Ratio | (1.92) |
Fortress Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fortress Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Fortress Biotech Corporate Management
| Samuel Berry | Gen Sec | Profile | |
| Robyn Hunter | Ex Officer | Profile | |
| Michael Esq | Vice Devel | Profile | |
| Thomas Schaible | Project Disease | Profile | |
| David Jin | CFO Devel | Profile |
Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.